Browsing Tag
PI3K/mTOR pathway
1 post
Torqur AG reports promising Phase 2 results for bimiralisib, full data expected by June
Torqur AG, a biotechnology company specializing in oncology and dermatology treatments, has presented interim Phase 2 clinical trial…